Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Aneurysm | 15 | 2025 | 200 | 2.320 |
Why?
|
| Embolization, Therapeutic | 23 | 2021 | 265 | 2.280 |
Why?
|
| Endovascular Procedures | 16 | 2021 | 310 | 1.930 |
Why?
|
| Cerebral Angiography | 23 | 2025 | 212 | 1.800 |
Why?
|
| Intracranial Arteriovenous Malformations | 14 | 2019 | 119 | 1.670 |
Why?
|
| Stents | 17 | 2022 | 416 | 1.650 |
Why?
|
| Thrombectomy | 7 | 2021 | 198 | 1.440 |
Why?
|
| Magnetic Resonance Angiography | 15 | 2019 | 273 | 1.220 |
Why?
|
| Brain Ischemia | 8 | 2020 | 404 | 1.150 |
Why?
|
| Central Nervous System Vascular Malformations | 6 | 2014 | 42 | 1.120 |
Why?
|
| Stroke | 11 | 2022 | 1038 | 1.080 |
Why?
|
| Neurosurgical Procedures | 5 | 2020 | 313 | 0.910 |
Why?
|
| Angiography, Digital Subtraction | 12 | 2018 | 98 | 0.890 |
Why?
|
| Cerebrovascular Circulation | 7 | 2015 | 230 | 0.850 |
Why?
|
| Aneurysm, Ruptured | 5 | 2021 | 60 | 0.830 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2019 | 43 | 0.830 |
Why?
|
| Carotid Artery Diseases | 4 | 2019 | 102 | 0.790 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2015 | 144 | 0.770 |
Why?
|
| Postoperative Complications | 8 | 2020 | 2452 | 0.720 |
Why?
|
| Intracranial Embolism | 1 | 2019 | 29 | 0.620 |
Why?
|
| Carotid Artery, Internal, Dissection | 4 | 2011 | 31 | 0.610 |
Why?
|
| Polyvinyls | 4 | 2013 | 21 | 0.580 |
Why?
|
| Carotid Artery, Internal | 5 | 2016 | 70 | 0.580 |
Why?
|
| Carotid Stenosis | 4 | 2022 | 116 | 0.560 |
Why?
|
| Cerebrovascular Disorders | 4 | 2019 | 144 | 0.540 |
Why?
|
| Algorithms | 4 | 2015 | 1960 | 0.510 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2020 | 146 | 0.500 |
Why?
|
| Arteriovenous Fistula | 5 | 2014 | 54 | 0.490 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2013 | 41 | 0.480 |
Why?
|
| Neuroimaging | 2 | 2019 | 127 | 0.480 |
Why?
|
| Humans | 81 | 2025 | 92335 | 0.470 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 102 | 0.470 |
Why?
|
| Computed Tomography Angiography | 4 | 2025 | 156 | 0.470 |
Why?
|
| Spinal Cord | 3 | 2014 | 246 | 0.450 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2025 | 3518 | 0.450 |
Why?
|
| Catheterization | 2 | 2018 | 236 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2025 | 2686 | 0.410 |
Why?
|
| Treatment Outcome | 26 | 2022 | 8724 | 0.410 |
Why?
|
| Cranial Sinuses | 3 | 2021 | 15 | 0.400 |
Why?
|
| Female | 48 | 2021 | 47910 | 0.400 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2019 | 607 | 0.390 |
Why?
|
| Cavernous Sinus | 2 | 2011 | 16 | 0.380 |
Why?
|
| Vasospasm, Intracranial | 2 | 2011 | 35 | 0.380 |
Why?
|
| Angiography | 2 | 2012 | 205 | 0.370 |
Why?
|
| Male | 48 | 2021 | 43922 | 0.340 |
Why?
|
| Aged | 27 | 2021 | 19946 | 0.340 |
Why?
|
| Postpartum Period | 1 | 2011 | 159 | 0.330 |
Why?
|
| Retrospective Studies | 23 | 2021 | 9682 | 0.310 |
Why?
|
| Polymethacrylic Acids | 1 | 2009 | 3 | 0.310 |
Why?
|
| Vertebroplasty | 1 | 2009 | 13 | 0.310 |
Why?
|
| Fractures, Compression | 1 | 2009 | 20 | 0.300 |
Why?
|
| Spinal Fractures | 1 | 2009 | 92 | 0.280 |
Why?
|
| Middle Aged | 31 | 2021 | 27048 | 0.280 |
Why?
|
| Adult | 23 | 2021 | 27555 | 0.280 |
Why?
|
| Mass Screening | 1 | 2013 | 675 | 0.280 |
Why?
|
| Hemangioma | 1 | 2008 | 64 | 0.280 |
Why?
|
| Spinal Neoplasms | 1 | 2008 | 77 | 0.260 |
Why?
|
| Neck | 1 | 2007 | 96 | 0.260 |
Why?
|
| Sensitivity and Specificity | 10 | 2019 | 2009 | 0.260 |
Why?
|
| Head | 1 | 2007 | 127 | 0.260 |
Why?
|
| Pulmonary Artery | 1 | 2008 | 330 | 0.250 |
Why?
|
| Hemodynamics | 3 | 2013 | 758 | 0.240 |
Why?
|
| Vertebral Artery | 2 | 2016 | 27 | 0.220 |
Why?
|
| Cerebral Revascularization | 3 | 2014 | 27 | 0.210 |
Why?
|
| Image Enhancement | 5 | 2019 | 562 | 0.200 |
Why?
|
| Middle Cerebral Artery | 3 | 2016 | 22 | 0.200 |
Why?
|
| Lumbar Vertebrae | 2 | 2020 | 290 | 0.190 |
Why?
|
| Reperfusion | 2 | 2020 | 32 | 0.190 |
Why?
|
| Treatment Failure | 2 | 2021 | 289 | 0.190 |
Why?
|
| Cerebral Arteries | 3 | 2013 | 75 | 0.190 |
Why?
|
| Graves Ophthalmopathy | 2 | 2012 | 3 | 0.190 |
Why?
|
| Optic Nerve Diseases | 2 | 2012 | 17 | 0.190 |
Why?
|
| Risk Assessment | 6 | 2022 | 2370 | 0.180 |
Why?
|
| Deception | 1 | 2022 | 20 | 0.180 |
Why?
|
| Blood Flow Velocity | 4 | 2015 | 198 | 0.180 |
Why?
|
| Endarterectomy, Carotid | 1 | 2022 | 75 | 0.180 |
Why?
|
| Thoracic Vertebrae | 2 | 2020 | 74 | 0.180 |
Why?
|
| Carotid Arteries | 2 | 2021 | 134 | 0.180 |
Why?
|
| Embolic Protection Devices | 1 | 2021 | 9 | 0.180 |
Why?
|
| After-Hours Care | 1 | 2021 | 8 | 0.170 |
Why?
|
| Embolism | 1 | 2021 | 33 | 0.170 |
Why?
|
| Burnout, Professional | 1 | 2022 | 104 | 0.170 |
Why?
|
| Spinal Cord Ischemia | 1 | 2020 | 8 | 0.170 |
Why?
|
| Risk Factors | 8 | 2022 | 5703 | 0.170 |
Why?
|
| Artifacts | 2 | 2012 | 246 | 0.160 |
Why?
|
| Radiography | 4 | 2013 | 795 | 0.160 |
Why?
|
| Basilar Artery | 1 | 2020 | 40 | 0.160 |
Why?
|
| Diagnosis, Differential | 5 | 2012 | 1593 | 0.160 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 6916 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2020 | 24 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 129 | 0.150 |
Why?
|
| Computer Graphics | 1 | 2019 | 101 | 0.150 |
Why?
|
| Neutrophils | 1 | 2020 | 323 | 0.150 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 196 | 0.150 |
Why?
|
| Observer Variation | 3 | 2015 | 611 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2019 | 2979 | 0.150 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2021 | 226 | 0.150 |
Why?
|
| Lymphocytes | 1 | 2020 | 476 | 0.140 |
Why?
|
| Vascular Closure Devices | 1 | 2018 | 3 | 0.140 |
Why?
|
| Microsurgery | 1 | 2019 | 96 | 0.140 |
Why?
|
| Calcinosis | 1 | 2019 | 230 | 0.140 |
Why?
|
| Angioplasty, Balloon | 2 | 2009 | 98 | 0.140 |
Why?
|
| Aneurysm, False | 2 | 2016 | 54 | 0.140 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 157 | 0.140 |
Why?
|
| Cerebral Veins | 3 | 2013 | 30 | 0.140 |
Why?
|
| Catheters | 1 | 2018 | 86 | 0.140 |
Why?
|
| Neuroendoscopy | 1 | 2018 | 20 | 0.140 |
Why?
|
| Intracranial Hypertension | 2 | 2016 | 59 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 190 | 0.140 |
Why?
|
| Child | 9 | 2021 | 7307 | 0.140 |
Why?
|
| Incidence | 3 | 2020 | 1658 | 0.140 |
Why?
|
| Aortic Valve | 1 | 2019 | 260 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 148 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 694 | 0.140 |
Why?
|
| Spinal Diseases | 2 | 2020 | 75 | 0.140 |
Why?
|
| ROC Curve | 3 | 2015 | 786 | 0.130 |
Why?
|
| Thrombosis | 1 | 2020 | 313 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 131 | 0.130 |
Why?
|
| Contrast Media | 6 | 2015 | 1077 | 0.130 |
Why?
|
| Polymers | 1 | 2018 | 201 | 0.130 |
Why?
|
| Inpatients | 2 | 2022 | 333 | 0.130 |
Why?
|
| Reproducibility of Results | 8 | 2019 | 2793 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2021 | 392 | 0.130 |
Why?
|
| Prevalence | 3 | 2021 | 1297 | 0.130 |
Why?
|
| Superior Sagittal Sinus | 1 | 2016 | 2 | 0.120 |
Why?
|
| Mechanical Thrombolysis | 1 | 2016 | 17 | 0.120 |
Why?
|
| Radiation Exposure | 1 | 2016 | 23 | 0.120 |
Why?
|
| Surgical Instruments | 1 | 2015 | 61 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2016 | 231 | 0.110 |
Why?
|
| Physicians | 1 | 2022 | 694 | 0.110 |
Why?
|
| Oculomotor Muscles | 2 | 2012 | 29 | 0.110 |
Why?
|
| Recurrence | 2 | 2016 | 1180 | 0.110 |
Why?
|
| Hospital Costs | 1 | 2015 | 114 | 0.110 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 253 | 0.110 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2014 | 5 | 0.110 |
Why?
|
| Emergencies | 2 | 2021 | 123 | 0.110 |
Why?
|
| Capillary Permeability | 1 | 2015 | 132 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 39 | 0.110 |
Why?
|
| Equipment Design | 2 | 2018 | 420 | 0.100 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2014 | 67 | 0.100 |
Why?
|
| Patient Selection | 2 | 2021 | 689 | 0.100 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2013 | 18 | 0.100 |
Why?
|
| Fistula | 1 | 2013 | 42 | 0.100 |
Why?
|
| Gadolinium | 1 | 2013 | 104 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1275 | 0.100 |
Why?
|
| Causality | 1 | 2013 | 80 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2015 | 800 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 63 | 0.100 |
Why?
|
| Orbital Diseases | 1 | 2012 | 17 | 0.090 |
Why?
|
| Spine | 2 | 2013 | 129 | 0.090 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2011 | 4 | 0.090 |
Why?
|
| Occipital Bone | 1 | 2011 | 14 | 0.090 |
Why?
|
| Astrocytoma | 1 | 2012 | 87 | 0.090 |
Why?
|
| Length of Stay | 1 | 2015 | 789 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2013 | 159 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2016 | 4464 | 0.090 |
Why?
|
| Angioplasty | 3 | 2021 | 71 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 351 | 0.090 |
Why?
|
| Vertebral Artery Dissection | 1 | 2011 | 20 | 0.090 |
Why?
|
| Vein of Galen Malformations | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 92 | 0.090 |
Why?
|
| Syndrome | 1 | 2011 | 448 | 0.090 |
Why?
|
| Carotid Artery, External | 1 | 2010 | 9 | 0.080 |
Why?
|
| Adolescent | 7 | 2021 | 9492 | 0.080 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Anticoagulants | 2 | 2011 | 448 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2014 | 497 | 0.080 |
Why?
|
| Cranial Nerve Diseases | 1 | 2010 | 8 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 3775 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 446 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2021 | 3806 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2012 | 405 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 174 | 0.080 |
Why?
|
| Thalamic Diseases | 1 | 2009 | 4 | 0.080 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 28 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2009 | 22 | 0.080 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 34 | 0.080 |
Why?
|
| Back Pain | 1 | 2009 | 64 | 0.080 |
Why?
|
| Moyamoya Disease | 1 | 2009 | 21 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 986 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 130 | 0.070 |
Why?
|
| Subdural Effusion | 1 | 2008 | 2 | 0.070 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 4 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2009 | 121 | 0.070 |
Why?
|
| Aortography | 1 | 2008 | 63 | 0.070 |
Why?
|
| Blood Patch, Epidural | 1 | 2008 | 10 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 42 | 0.070 |
Why?
|
| Neuronavigation | 1 | 2008 | 22 | 0.070 |
Why?
|
| Pediatrics | 1 | 2012 | 370 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 361 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2009 | 163 | 0.070 |
Why?
|
| Neck Pain | 1 | 2008 | 40 | 0.070 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2008 | 110 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 202 | 0.070 |
Why?
|
| Infant | 4 | 2016 | 3206 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 159 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 168 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2009 | 290 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 186 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2021 | 2505 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2021 | 955 | 0.060 |
Why?
|
| Neurofibromatosis 2 | 1 | 2005 | 11 | 0.060 |
Why?
|
| Hypertension | 1 | 2011 | 762 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2016 | 152 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2005 | 73 | 0.060 |
Why?
|
| United States | 3 | 2022 | 7366 | 0.050 |
Why?
|
| Time Factors | 3 | 2021 | 5428 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1238 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 807 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1206 | 0.050 |
Why?
|
| Young Adult | 4 | 2021 | 6619 | 0.050 |
Why?
|
| Fatigue | 1 | 2022 | 177 | 0.040 |
Why?
|
| Medical Errors | 1 | 2022 | 116 | 0.040 |
Why?
|
| Brain | 2 | 2009 | 2355 | 0.040 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2021 | 11 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2022 | 132 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2022 | 100 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 592 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 1733 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2021 | 33 | 0.040 |
Why?
|
| North America | 1 | 2021 | 189 | 0.040 |
Why?
|
| Infarction | 1 | 2020 | 27 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 2012 | 124 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 162 | 0.040 |
Why?
|
| Patient Admission | 1 | 2020 | 115 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2021 | 245 | 0.040 |
Why?
|
| Stereotaxic Techniques | 2 | 2009 | 82 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 402 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 445 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2018 | 64 | 0.030 |
Why?
|
| Disease Progression | 2 | 2014 | 1500 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 1761 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2018 | 120 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 478 | 0.030 |
Why?
|
| Chicago | 1 | 2021 | 1463 | 0.030 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2016 | 14 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 300 | 0.030 |
Why?
|
| Patient Safety | 1 | 2018 | 220 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 219 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2015 | 66 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2018 | 300 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1891 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 108 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 739 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 2734 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 260 | 0.030 |
Why?
|
| Shear Strength | 1 | 2013 | 17 | 0.030 |
Why?
|
| Herpes Zoster | 1 | 2014 | 79 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1847 | 0.030 |
Why?
|
| Aneurysm | 1 | 2013 | 60 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 108 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2013 | 64 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 256 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2013 | 185 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 63 | 0.020 |
Why?
|
| Illinois | 1 | 2014 | 502 | 0.020 |
Why?
|
| Magnetic Fields | 1 | 2012 | 11 | 0.020 |
Why?
|
| Orbit | 1 | 2012 | 39 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 900 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 852 | 0.020 |
Why?
|
| Diplopia | 1 | 2011 | 13 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 317 | 0.020 |
Why?
|
| Dura Mater | 1 | 2011 | 47 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 373 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 220 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 337 | 0.020 |
Why?
|
| Pain | 1 | 2013 | 406 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 167 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2011 | 83 | 0.020 |
Why?
|
| Temporal Arteries | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 92 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 209 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 1926 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 997 | 0.020 |
Why?
|
| Decision Trees | 1 | 2009 | 62 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2009 | 70 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1769 | 0.020 |
Why?
|
| Transplants | 1 | 2009 | 43 | 0.020 |
Why?
|
| Myelography | 1 | 2008 | 12 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2009 | 157 | 0.020 |
Why?
|
| Hematoma, Subdural | 1 | 2008 | 28 | 0.020 |
Why?
|
| Encephalocele | 1 | 2008 | 25 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1905 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 331 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2008 | 53 | 0.020 |
Why?
|
| Thalamus | 1 | 2009 | 133 | 0.020 |
Why?
|
| Craniotomy | 1 | 2008 | 92 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 190 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2009 | 239 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1921 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 355 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2008 | 180 | 0.020 |
Why?
|
| Hemianopsia | 1 | 2005 | 4 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 1075 | 0.010 |
Why?
|
| Paresis | 1 | 2005 | 16 | 0.010 |
Why?
|
| Reoperation | 1 | 2008 | 652 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1196 | 0.010 |
Why?
|
| Aphasia | 1 | 2005 | 15 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 2005 | 29 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2008 | 710 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 461 | 0.010 |
Why?
|
| Meningioma | 1 | 2005 | 66 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 389 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 4217 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 28055 | 0.010 |
Why?
|